In an exciting turn of events, renowned healthcare company Novo Nordisk has teamed up with Life Edit Therapeutics to explore and develop...

Biotech company Pneumagen has successfully procured £8 million in funding to propel the Phase 2 development of Neumifil, a groundbreaking...

Novo Nordisk, a global healthcare industry leader, is in exclusive talks to acquire a controlling interest in BIOCORP. Following the...

Novo Nordisk, a leading global healthcare company based in Denmark, has recently announced a significant investment plan. The investment,...

In an ever-evolving financial landscape, innovative strategies are key for companies seeking growth. PharmAla Biotech, a renowned name in...

Introduction Cytomegalovirus (CMV) is a common opportunistic infection that poses significant risks to transplant recipients. To address...

Introduction Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company, has recently made significant strides...

Introduction Parkinson's disease (PD) affects millions of people worldwide, making it the second-leading neurodegenerative disease. While...

Introduction Mithra, a leading pharmaceutical company, has recently announced its access to a new tranche of the Highbridge/Whitebox loan...

Orchard Therapeutics, a global leader in gene therapy, has successfully completed the second closing of its securities purchase...

Axsome Therapeutics, a renowned biopharmaceutical company specializing in the development and delivery of innovative therapies for...

Rare diseases affect millions of individuals and families worldwide, often leaving them without adequate treatment options or support. In...